SBC Medical Group (NASDAQ:SBC) Shares Gap Down – Here’s What Happened

SBC Medical Group Holdings Incorporated (NASDAQ:SBC)’s share price gapped down before the market opened on Wednesday. The stock had previously closed at $5.37, but opened at $5.19. SBC Medical Group shares last traded at $5.3450, with a volume of 21,291 shares changing hands.

Analyst Ratings Changes

A number of equities analysts have commented on SBC shares. Wall Street Zen raised shares of SBC Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Monday, October 5th. BTIG Research reissued a “buy” rating and issued a $8.00 price objective on shares of SBC Medical Group in a research report on Thursday, August 13th. Finally, Weiss Ratings upgraded shares of SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. Two analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, SBC Medical Group has a consensus rating of “Moderate Buy” and a consensus target price of $8.50.

SBC Medical Group Stock Up 4.4%

The company has a market cap of $585.22 million, a price-to-earnings ratio of 11.60, a P/E/G ratio of 2.45 and a beta of 0.56. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.31 and a quick ratio of 3.27. The firm has a 50-day moving average price of $4.84 and a 200 day moving average price of $3.92.

SBC Medical Group (NASDAQ:SBC) last released its quarterly earnings results on Thursday, August 13th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.02). The firm had revenue of $49.19 million for the quarter, compared to analyst estimates of $45.37 million. SBC Medical Group had a return on equity of 18.47% and a net margin of 27.99%. Sell-side analysts predict that SBC Medical Group Holdings Incorporated will post 0.44 EPS for the current year.

Institutional Investors Weigh In On SBC Medical Group

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Nisa Investment Advisors LLC acquired a new stake in SBC Medical Group in the 3rd quarter worth about $36,000. Bank of New York Mellon Corp acquired a new position in shares of SBC Medical Group during the 1st quarter worth approximately $43,000. Bank of America Corp DE bought a new position in shares of SBC Medical Group during the second quarter worth approximately $35,000. Williams & Novak LLC increased its holdings in shares of SBC Medical Group by 31.2% during the second quarter. Williams & Novak LLC now owns 18,686 shares of the company’s stock worth $58,000 after purchasing an additional 4,449 shares during the period. Finally, Deutsche Bank AG bought a new position in shares of SBC Medical Group during the second quarter worth approximately $58,000. Institutional investors and hedge funds own 60.82% of the company’s stock.

About SBC Medical Group

SBC Medical Group Holdings Incorporated is a Japan-based healthcare services company focused on supporting aesthetic medicine and related medical institutions. Through its group companies, the business provides operational and management support designed to help clinics deliver cosmetic surgery, dermatology, and other elective medical services.

The company’s services include clinic management consulting, marketing, staff recruitment and training, procurement, information technology, and administrative support.